4//SEC Filing
EMIGH JAMES F 4
Accession 0001209191-13-024112
CIK 0000786947other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 12:45 PM ET
Size
7.5 KB
Accession
0001209191-13-024112
Insider Transaction Report
Form 4
EMIGH JAMES F
VP Marketing & Administration
Transactions
- Exercise/Conversion
Common Stock
2013-05-03$1.30/sh+6,225$8,093→ 177,079 total - Exercise/Conversion
Stock Options
2013-05-03−6,225→ 6,225 totalExercise: $1.30From: 2013-01-01Exp: 2014-03-09→ Common Stock (6,225 underlying)
Footnotes (3)
- [F1]Amount of securities include 38,875 Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) on January 1st of 2014.
- [F2]Option is exercsiable with respect to 6,225 shares commencing January 1, 2013. Remaining portion of option is exercisable (absent a change of control) commencing on January 1, 2014, and must be exercised in year in which it first becomes exercisable.
- [F3]N/A
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
IncorporatedNY
Related Parties
1- filerCIK 0001107934
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 12:45 PM ET
- Size
- 7.5 KB